Please use this identifier to cite or link to this item:
|Title:||High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoid Salmonella clinical isolates in Asia||Authors:||Lee, H.-Y.
|Issue Date:||Jun-2009||Citation:||Lee, H.-Y., Su, L.-H., Tsai, M.-H., Kim, S.-W., Chang, H.-H., Jung, S.-I., Park, K.-H., Perera, J., Carlos, C., Ban, H.T., Kumarasinghe, G., So, T., ChongthaLeong, A., Hsueh, P.-R., Liu, J.-W., Song, J.-H., Chiu, C.-H. (2009-06). High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoid Salmonella clinical isolates in Asia. Antimicrobial Agents and Chemotherapy 53 (6) : 2696-2699. ScholarBank@NUS Repository. https://doi.org/10.1128/AAC.01297-08||Abstract:||This multinational study from Asia revealed that reduced susceptibility to ciprofloxacin (MIC, 0.125 to 1 μg/ml) in nontyphoid Salmonella isolates was common in Taiwan (48.1%) and Thailand (46.2%) and in S. enterica serotype Choleraesuis (68.8%) and S. Virchow (75.0%) from all countries. Reduced susceptibility to ceftriaxone (MIC, 2 to 8 μg/ml) remained uncommon in Asia, except in Taiwan (38.0%) or in S. Typhimurium (25.0%) from all countries. Copyright © 2009, American Society for Microbiology. All Rights Reserved.||Source Title:||Antimicrobial Agents and Chemotherapy||URI:||http://scholarbank.nus.edu.sg/handle/10635/133364||ISSN:||00664804||DOI:||10.1128/AAC.01297-08|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.